|
US4551433A
(en)
|
1981-05-18 |
1985-11-05 |
Genentech, Inc. |
Microbial hybrid promoters
|
|
US4462940A
(en)
|
1982-09-23 |
1984-07-31 |
Cetus Corporation |
Process for the recovery of human β-interferon-like polypeptides
|
|
US5702699A
(en)
|
1982-09-23 |
1997-12-30 |
Cetus Corporation |
Process for the recovery of lipophilic proteins
|
|
US4992271A
(en)
|
1982-09-23 |
1991-02-12 |
Cetus Corporation |
Formulation for lipophilic IL-2 proteins
|
|
US5643566A
(en)
|
1982-09-23 |
1997-07-01 |
Cetus Corporation |
Formulation processes for lipophilic proteins
|
|
US4588585A
(en)
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
|
US4755465A
(en)
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
|
US5281532A
(en)
|
1983-07-27 |
1994-01-25 |
Mycogen Corporation |
Pseudomas hosts transformed with bacillus endotoxin genes
|
|
US4695462A
(en)
|
1985-06-28 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of biological pesticides
|
|
US4695455A
(en)
|
1985-01-22 |
1987-09-22 |
Mycogen Corporation |
Cellular encapsulation of pesticides produced by expression of heterologous genes
|
|
GB8517071D0
(en)
|
1985-07-05 |
1985-08-14 |
Hoffmann La Roche |
Gram-positive expression control sequence
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
US4734362A
(en)
*
|
1986-02-03 |
1988-03-29 |
Cambridge Bioscience Corporation |
Process for purifying recombinant proteins, and products thereof
|
|
DK203187A
(da)
|
1986-04-22 |
1987-10-23 |
Immunex Corp |
Human g-csf proteinekspression
|
|
US5183746A
(en)
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
|
JP2618618B2
(ja)
|
1988-03-04 |
1997-06-11 |
協和醗酵工業株式会社 |
抗ｇ−ｃｓｆ誘導体、ｎｄ２８モノクローナル抗体
|
|
NO176799C
(no)
|
1986-12-23 |
1995-05-31 |
Kyowa Hakko Kogyo Kk |
DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid
|
|
US4904584A
(en)
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
|
US5128130A
(en)
|
1988-01-22 |
1992-07-07 |
Mycogen Corporation |
Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
|
|
US5055294A
(en)
|
1988-03-03 |
1991-10-08 |
Mycogen Corporation |
Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
|
|
CA1340810C
(en)
|
1988-03-31 |
1999-11-02 |
Motoo Yamasaki |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
|
WO1990006952A1
(fr)
|
1988-12-22 |
1990-06-28 |
Kirin-Amgen, Inc. |
Facteur de stimulation de colonies de granulocytes modifies chimiquement
|
|
US6372206B1
(en)
|
1989-03-02 |
2002-04-16 |
University Of Florida |
Orally-administered interferon-TAU compositions and methods
|
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
|
US5169760A
(en)
|
1989-07-27 |
1992-12-08 |
Mycogen Corporation |
Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
|
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
|
DE4014750A1
(de)
|
1990-05-08 |
1991-11-14 |
Boehringer Mannheim Gmbh |
Muteine des granulozyten-stimulierenden faktors (g-csf)
|
|
IE912365A1
(en)
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
|
WO1992006116A1
(en)
|
1990-09-28 |
1992-04-16 |
Ortho Pharmaceutical Corporation |
Hybrid growth factors
|
|
US5508192A
(en)
|
1990-11-09 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Bacterial host strains for producing proteolytically sensitive polypeptides
|
|
US5240834A
(en)
*
|
1991-01-22 |
1993-08-31 |
Albert Einstein College Of Medicine Of Yeshiva University |
Solubilization of protein after bacterial expression using sarkosyl
|
|
DE4105480A1
(de)
|
1991-02-21 |
1992-08-27 |
Boehringer Mannheim Gmbh |
Verbesserte aktivierung von rekombinanten proteinen
|
|
US6171824B1
(en)
|
1991-08-30 |
2001-01-09 |
Fred Hutchinson Cancer Research Center |
Hybrid cytokines
|
|
US6057133A
(en)
|
1992-11-24 |
2000-05-02 |
G. D. Searle |
Multivariant human IL-3 fusion proteins and their recombinant production
|
|
ITFI940106A1
(it)
|
1994-05-27 |
1995-11-27 |
Menarini Ricerche Sud Spa |
Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
RU2098124C1
(ru)
*
|
1994-10-24 |
1997-12-10 |
Общество с ограниченной ответственностью "Ниготек" |
Способ получения интерферона
|
|
IT1285405B1
(it)
|
1995-06-06 |
1998-06-03 |
Alza Corp |
Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto.
|
|
US5814485A
(en)
|
1995-06-06 |
1998-09-29 |
Chiron Corporation |
Production of interferon-β (IFN-β) in E. coli
|
|
ATE550042T1
(de)
|
1997-11-20 |
2012-04-15 |
Vical Inc |
Behandlung von krebs mithilfe cytokin- exprimierender polynukleotide und zusammensetzungen dafür
|
|
EP1088888A4
(en)
|
1998-05-14 |
2005-03-16 |
Merck Patent Gmbh |
MERGED PROTEIN
|
|
US20030167531A1
(en)
|
1998-07-10 |
2003-09-04 |
Russell Douglas A. |
Expression and purification of bioactive, authentic polypeptides from plants
|
|
WO2000049146A1
(en)
|
1999-02-18 |
2000-08-24 |
Rmf Dictagene S.A. |
Malaria vaccine
|
|
US7001892B1
(en)
|
1999-06-11 |
2006-02-21 |
Purdue Research Foundation |
Pharmaceutical materials and methods for their preparation and use
|
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
|
KR100358948B1
(ko)
|
2000-03-31 |
2002-10-31 |
한국과학기술원 |
인체 과립성 백혈구의 콜로니 자극인자를 분비하는 대장균
|
|
MXPA03002045A
(es)
|
2000-09-08 |
2003-07-24 |
Amgen Inc |
Composiciones analogas de factor estimulador de colonias de granulocitos y metodos para su elaboracion.
|
|
EP1343518B1
(en)
|
2000-11-07 |
2009-07-22 |
Novartis Vaccines and Diagnostics, Inc. |
Stabilized interferon compositions
|
|
CA2437287A1
(en)
|
2001-02-06 |
2002-10-03 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
|
|
CN100522242C
(zh)
|
2001-02-19 |
2009-08-05 |
默克专利有限公司 |
具有降低的免疫原性的人工蛋白质
|
|
WO2002069232A2
(en)
|
2001-02-19 |
2002-09-06 |
Merck Patent Gmbh |
Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity
|
|
EP1425304B9
(en)
|
2001-07-11 |
2010-09-08 |
Maxygen, Inc. |
G-csf conjugates
|
|
WO2003023050A2
(en)
|
2001-09-10 |
2003-03-20 |
Emd Biosciences, Inc. |
Method for recovering and analyzing a cellular component of cultured cells without having to harvest the cells first
|
|
US20040247562A1
(en)
|
2001-09-28 |
2004-12-09 |
Sang Yup Lee |
Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
|
|
ES2411007T3
(es)
|
2001-10-10 |
2013-07-04 |
Novo Nordisk A/S |
Remodelación y glicoconjugación de péptidos
|
|
AU2003210806A1
(en)
|
2002-03-05 |
2003-09-22 |
Eli Lilly And Company |
Heterologous g-csf fusion proteins
|
|
SI21273A
(sl)
|
2002-07-31 |
2004-02-29 |
LEK farmacevtska dru�ba d.d. |
Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
|
|
KR100521309B1
(ko)
|
2002-08-31 |
2005-10-14 |
씨제이 주식회사 |
당쇄화된 인간 과립구 형성인자
|
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
|
US8399217B2
(en)
|
2003-03-14 |
2013-03-19 |
Brookhaven Science Associates, Llc |
High density growth of T7 expression strains with auto-induction option
|
|
WO2005052151A1
(en)
|
2003-11-19 |
2005-06-09 |
Dow Global Technologies Inc. |
Improved protein expression systems
|
|
CA2546157C
(en)
|
2003-11-21 |
2014-07-22 |
Dow Global Technolgies Inc. |
Improved expression systems with sec-system secretion
|
|
KR100524872B1
(ko)
*
|
2003-12-04 |
2005-11-01 |
씨제이 주식회사 |
인터페론 베타의 정제방법
|
|
EP1709170B1
(en)
|
2004-01-16 |
2018-02-21 |
Pfenex Inc. |
Expression of mammalian proteins in pseudomonas fluorescens
|
|
BRPI0513826A2
(pt)
|
2004-07-26 |
2010-06-22 |
Dow Global Technologies Inc |
processo para expressão de proteìna melhorada através de engenharia de cepa
|
|
JP4705113B2
(ja)
|
2004-12-20 |
2011-06-22 |
カディラ ヘルスケア リミティド |
高レベルのインターフェロンベータの調製方法
|
|
WO2006067170A1
(en)
|
2004-12-23 |
2006-06-29 |
Laboratoires Serono S.A. |
G-csf polypeptides and uses thereof
|
|
GB0605684D0
(en)
|
2006-03-21 |
2006-05-03 |
Sicor Biotech Uab |
Method For Purifying Granulocyte-Colony Stimulating Factor
|
|
EP2021489A2
(en)
|
2006-05-30 |
2009-02-11 |
Dow Global Technologies Inc. |
Codon optimization method
|
|
EP1939212A1
(en)
|
2006-12-20 |
2008-07-02 |
LEK Pharmaceuticals D.D. |
Organic compounds
|
|
EP2468869B1
(en)
|
2007-01-31 |
2015-03-18 |
Pfenex Inc. |
Bacterial leader sequences for increased expression
|
|
US9394571B2
(en)
|
2007-04-27 |
2016-07-19 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
US7625555B2
(en)
|
2007-06-18 |
2009-12-01 |
Novagen Holding Corporation |
Recombinant human interferon-like proteins
|
|
JP2010536341A
(ja)
|
2007-08-15 |
2010-12-02 |
アムニクス， インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
|
AU2010266093B2
(en)
|
2009-06-25 |
2013-06-27 |
Amgen Inc. |
Capture purification processes for proteins expressed in a non-mammalian system
|
|
EP2542574B1
(en)
|
2010-03-04 |
2017-08-09 |
Pfenex Inc. |
Method for producing soluble recombinant interferon protein without denaturing
|
|
AU2011235210B2
(en)
|
2010-04-01 |
2015-07-16 |
Pfenex Inc. |
Methods for G-CSF production in a Pseudomonas host cell
|